Efficacy of an Esophageal Spacer for Spine Radiosurgery: First Experience

Thomas Boerner; Chunzi Jenny Jin; Caitlin Harrington; Mark H Bilsky; Yoshiya Josh Yamada; Daniela Molena

doi:10.1016/j.prro.2022.02.010

Efficacy of an Esophageal Spacer for Spine Radiosurgery: First Experience

Pract Radiat Oncol. 2022 Jul-Aug;12(4):e312-e316. doi: 10.1016/j.prro.2022.02.010. Epub 2022 Mar 7.

Authors

Thomas Boerner¹, Chunzi Jenny Jin², Caitlin Harrington¹, Mark H Bilsky³, Yoshiya Josh Yamada⁴, Daniela Molena⁵

Affiliations

¹ Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
² Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada.
³ Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.
⁴ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
⁵ Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: molenad@mskcc.org.

Abstract

This is the first study to investigate the use of an esophageal hydrogel spacer in spine stereotactic radiosurgery. The tolerability and the dose reduction to the esophagus are predicted to reduce the incidence of high-grade toxicities, which in turn can permit dose escalation to optimize tumor control.

MeSH terms

Esophagus
Humans
Neurosurgical Procedures
Radiosurgery*
Spinal Neoplasms* / pathology
Spinal Neoplasms* / radiotherapy
Spinal Neoplasms* / surgery
Spine / pathology

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States